Gossamer Bio (GOSS) R&D/CAPEX US GAAP (year values) |
|||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 260.6% | 2 184% | 646.4% | 10 504% | 35 983% | 110.0% | |||
Changes by years, y/y, % | +1 923pp | -1 538pp | +9 857pp | +25 479pp | +242.8% |
Gossamer Bio. R&D/CAPEX, %
Gossamer Bio. R&D/CAPEX, changes, pp
Gossamer Bio (GOSS) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
R&D/CAPEX, % | 242 060% | 104 000% | 49 463% | 29.9% | 110.0% | |||
Changes by years, y/y, % | +210 519pp | +7 241pp | +13 986pp | -251 967pp | -242 030pp | |||
Changes by quarters, q/q, % | -9 907pp | -138 060pp | -54 537pp | -49 463pp |